In a nutshell This study aimed to investigate the effects of resveratrol on diabetic kidney disease. The main finding of the study was that resveratrol reduced the amount of protein lost in the urine in diabetic kidney disease. Some background Diabetic kidney disease (nephropathy) is a common complication of diabetes. One of the ways to measure kidney...
Read MoreIn a nutshell This study aimed to investigate the effect of canagliflozin (Invokana) use on bone fracture risk in patients with type 2 diabetes (T2D). The main finding of the study was that there was no increased risk of bone fractures with canagliflozin use. Some background Canagliflozin is an SGLT-2 inhibitor, used to treat T2D. It works by...
Read More
Dental health is a critical component of personal heath. For people living with diabetes, dental care is especially important since diabetes can compromise your immune system. There are between 200 and 300 bacteria in your mouth so remembering to brush at least twice a day needs to be part of your daily ritual. Although it is counter-intuitive, choosing a...
Read More
In a nutshell The aim of the study was to look at the relationship between insulin dose and risk of cardiovascular disease (CVD) in type 1 diabetes (T1D). The main finding of the study was that higher insulin doses are associated with CVD risk factors but not with increased CVD events. Some background Patients with T1D have an increased risk of CVD...
Read More
In a nutshell The aim of this study was to examine the effect of long-acting exenatide on blood sugar control, body weight and the thickness of the wall of the carotid artery in patients with type 2 diabetes (T2D). The main finding of the study was that this treatment improved all these parameters in patients with T2D. Some background Patients withT2D...
Read More
In a nutshell The aim of this study was to investigate the safety and effectiveness of ipragliflozin (Suglat) in the treatment of type 2 diabetes (T2D). The main finding of the study was that ipragliflozin was safe effective in the treatment of T2D and improved liver function. Some background Ipragliflozin is a blood sugar lowering drug used...
Read More
In a nutshell The aim of this study was to investigate the safety and effectiveness of a closed-loop insulin delivery system for day and night use in patients with type 1 diabetes (T1D). The main finding of the study was that this system was safe and had better blood glucose control than the sensor-augmented pump. Some background Insulin therapy is...
Read MoreIn a nutshell This trial is examining the effectiveness of tirzepatide compared to insulin glargine in patients with type 2 diabetes who are also at high risk for heart disease. The main outcome to be measured will be a change in HbA1c (a blood test that measures average blood sugar levels in the past 3 months) over 52 weeks. The details In type 2...
Read MoreIn a nutshell The aim of this study was to investigate the relationship between the use of incretin-based anti-diabetic drugs and the risk of hospitalization due to heart failure. The main finding of the study was that the use of these drugs is not associated with an increased risk of hospitalization due to heart failure. Some background There...
Read More
In a nutshell This study aimed to investigate the effects of a plant-based vegan meal versus a meat and cheese meal on gut hormones and satiety in healthy, obese, and med with type 2 diabetes. The main finding of the study is that there is an increase in gut hormones and satiety after a plant-based meal compared to a meat and cheese meal in these...
Read MoreIn a nutshell This trial is examining the safety and effectiveness of efpeglenatide versus dulaglutide in patients with poorly controlled type 2 diabetes (T2D) who are on metformin. The main outcome to be measured will be a change in HbA1c (blood test measuring average blood glucose over the past 3 months). This trial is being conducted in the United...
Read MoreIn a nutshell The aim of this study is the test the effectiveness of new drug BTI320 on blood glucose control in type 2 diabetes (T2D). The main outcome to be measured will be a change in blood glucose 2 hours after meals. This study is being carried out in the United States. The details The number of patients with T2D is constantly on the rise....
Read More
